title: [Uterine adenomatoid tumors: a clinicopathologic analysis of 25 cases].
authors.affiliation: zxyylxl@163.com
authors.forename: Xiao-ling
authors.initials: XL
authors.lastname: Liu
authors.forename: Hong-fang
authors.initials: HF
authors.lastname: Chen
authors.forename: Jin-sheng
authors.initials: JS
authors.lastname: Shi
authors.forename: Jing-jing
authors.initials: JJ
authors.lastname: Wen
authors.forename: Pei-jun
authors.initials: PJ
authors.lastname: Zong
mesh_terms: D000230:Adenocarcinoma / Q000473:pathology; D018254:Adenomatoid Tumor / Q000378:metabolism / Q000473:pathology* / Q000601:surgery; D018194:Adenomyoma / Q000473:pathology; D000328:Adult; D058846:Antibodies, Monoclonal, Murine-Derived / Q000378:metabolism; D014408:Biomarkers, Tumor / Q000378:metabolism; D064032:Calbindin 2 / Q000378:metabolism; D003937:Diagnosis, Differential; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007633:Keratins / Q000378:metabolism; D007889:Leiomyoma / Q000473:pathology; D018190:Neoplasm, Lymphatic Tissue / Q000378:metabolism / Q000473:pathology; D008875:Middle Aged; D014594:Uterine Neoplasms / Q000378:metabolism / Q000473:pathology* / Q000601:surgery; D055815:Young Adult; D000951:Antigens, Neoplasm
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D014408:Biomarkers, Tumor; D064032:Calbindin 2; D007633:Keratins; C432845:HBME-1 antigen; D000951:Antigens, Neoplasm; C500987:monoclonal antibody D2-40